Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.
Brief Summary:
To evaluate the chemical efficacy and safety of intranasally administered peptide T on neurocognitive function in HIV seropositive individuals.
Previous studies have shown that treatment with peptide T can result in cognitive improvement in HIV-infected patients.
Patients are randomized to receive either peptide T or placebo for the first 6 months. All patients then receive open-label peptide T for approximately 6 additional months. Neuropsychologic tests are used to determine drug effects.